Patents Assigned to ATHENEX R&D. LLC
  • Polymorphisms of HM30181 mesylate
    Patent number: 11739079
    Abstract: HM30181 (shown below) can be used to improve absorption of cancer chemotherapy drugs, such as paclitaxel. Herein are described various polymorphisms of HM30181, in particular polymorphism C, as well as their physical properties and methods for their preparation and characterization.
    Type: Grant
    Filed: October 28, 2021
    Date of Patent: August 29, 2023
    Assignee: ATHENEX R&D. LLC
    Inventors: Sameer Urgaonkar, Michael P. Smolinski, Johnson Yiu-Nam Lau